In this study, we searched for CHEK2 mutations in young, high-risk breast cancer patients in China and detected a missense variant Y390C (1169A &gt; G) in 12 of 150 patients (8.0%) and 2 in 250 healthy controls (0.8%, P = 0.0002).
C0006142
Malignant neoplasm of breast